SavedAdd your journal

Journals / art / 2020 / Cilt: 35 - Sayı: 3

Comparison of Beta-2 Adrenergic Receptor Gene Polymorphisms Between Patients With Fibromyalgia Syndrome and Healthy Controls

Gözde ŞEN ÇAKIROĞLU
Sami HİZMETLİ
YAVUZ SİLİĞ
AHMET KARADAĞ
Emrullah HAYTA
Burcu ÖZALTIN
AYÇA TAŞ
Cemile ZONTUL
Journal
art
Pages
328–334
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results of the present study will light the way for future research into ADRB2 gene polymorphisms in the pathogenesis of FMS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to compare the beta-2 adrenergic receptor (ADRB2) gene polymorphisms of patients with fibromyalgia syndrome (FMS) with those of healthy control subjects, and to investigate the possible relationship between symptoms of FMS and polymorphisms of the ADRB2 gene.
📊
Key Findings & Data:Patients and methods: The study included 170 females (mean age 47.8±10.3 years; range, 21 to 75 years) diagnosed with FMS according to the 2010 American College of Rheumatology criteria and 170 healthy females (mean age 47.2±8.8 years; range, 20 to 72 years) as the control group.
💡
Conclusion & Impact:The results of the present study will light the way for future research into ADRB2 gene polymorphisms in the pathogenesis of FMS.
🔬Design:Survey & Empirical Study
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to compare the beta-2 adrenergic receptor (ADRB2) gene polymorphisms of patients with fibromyalgia syndrome (FMS) with those of healthy control subjects, and to investigate the possible relationship between symptoms of FMS and polymorphisms of the ADRB2 gene. Patients and methods: The study included 170 females (mean age 47.8±10.3 years; range, 21 to 75 years) diagnosed with FMS according to the 2010 American College of Rheumatology criteria and 170 healthy females (mean age 47.2±8.8 years; range, 20 to 72 years) as the control group. Several clinical symptoms of the participants related to FMS were questioned and recorded. The visual analog scale (VAS) and Fibromyalgia Impact Questionnaire (FIQ) scores of the fibromyalgia group were recorded. In both groups, the ADRB2 (rs1042717) single-nucleotide polymorphism was detected by way of a real-time polymerase chain reaction. The wild-type (Guanine/Guanine), the mutant type (Adenine/Adenine) and heterozygous type (Adenine/Guanine) were detected. The sample power was calculated considering the minor allele frequency. Results: The comparison of the ADRB2 gene polymorphism between patients with FMS and the control subjects showed that the groups were similar in terms of ADBR2 gene polymorphism and genotype (p>0.05). There was no significant difference in terms of genotype when the ADRB2 gene polymorphisms in patients with FMS were compared in terms of clinical symptoms, VAS and FIQ scores (p>0.05). Conclusion: Beta-2 adrenergic receptor (rs1042717) gene polymorphisms and genotype distribution are no different between patients with FMS and healthy individuals. ADRB2 gene polymorphisms in patients with FMS have no effect on clinical symptoms and VAS and FIQ scores. The results of the present study will light the way for future research into ADRB2 gene polymorphisms in the pathogenesis of FMS.

🔖

Cite This Article

ÇAKIROĞLU, G. Ş., HİZMETLİ, S., SİLİĞ, Y., KARADAĞ, A., HAYTA, E., ÖZALTIN, B., TAŞ, A., ZONTUL, C. (2020). Comparison of Beta-2 Adrenergic Receptor Gene Polymorphisms Between Patients With Fibromyalgia Syndrome and Healthy Controls. art, Cilt: 35 - Sayı: 3, 328–334. https://ajindex.com/articles/142820

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Metyas S, Rezk T, Arkfeld D, Leptich T. Autoinflammation and Immunomodulation in Inflammatory Fibromyalgia Syndrome- A Review. Curr Rheumatol Rev 2017;13:98-102.
  2. Dadabhoy D, Clauw DJ. Therapy Insight: fibromyalgia- -a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2006;2:364-72.
  3. Albrecht PJ, Rice FL. Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms. Rev Environ Health 2016;31:281-94. Martínez-Lavín M, Hermosillo AG. Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 2000;29:197-9.
  4. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14:135-43.
  5. Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012;2012:426130. Martínez-Martínez LA, Mora T, Vargas A, Fuentes- Iniestra M, Martínez-Lavín M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol 2014;20:146-50. Buskila D. Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther 2009;11:242. Ablin J, Neumann L, Buskila D. Pathogenesis of fibromyalgia - a review. Joint Bone Spine 2008;75:273-9.
  6. Giacomelli C, Sernissi F, Sarzi-Puttini P, Di Franco M, Atzeni F, Bazzichi L. Fibromyalgia: a critical digest of the recent literature. Clin Exp Rheumatol 2013;31:S153-7. Gürsoy S, Erdal E, Herken H, Madenci E, Alaehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003;23:104-7. Josep García-Fructuoso F, Ignacio Lao-Villadóniga J, Beyer K, Santos C. Relationship between COMT gene genotypes and severity of fibromyalgia. Reumatol Clin 2006;2:168-72. Vargas-Alarcón G, Fragoso JM, Cruz-Robles D, Vargas A, Vargas A, Lao-Villadóniga JI, et al. Catechol-Omethyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 2007;9:R110. Bozkaya ÖG. Klinisyenler için mutasyon ve polimorfizm. Turkiye Klinikleri J Pediatr 2009;18:47-53.
  7. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic